$13.25
-0.34 (-2.50%)
PATH News30 articles
UiPath Stock Climbs 8% on Gartner Leader Nod; ARR Growth Steady at 12%
UiPath (PATH) surged 8% after Gartner again named it a Leader in Intelligent Document Processing, adding $582M in market value. ARR growth stays at 12%, leaving investors to weigh the news's impact.
UiPath Rally: Survey Hype vs. Revenue Reality
UiPath shares ticked up 2.2% on Thursday, but a new survey's 89% ROI figure hasn't translated into revenue growth. The company faces a critical test at its September 22 Investor Day.
UiPath Stock Tumbles 16.6% Despite Beat: The ARR Acceleration Challenge
UiPath (PATH) shares dropped 16.6% post-earnings despite a revenue beat, as investors focus on a steep second-half ARR acceleration requirement. The company must add $129.5M in net new ARR, 52% more than H1.
UiPath Shares Tumble 17% as Guidance Lift Masks Tepid H2 Outlook
UiPath shares fell 16.63% on Friday despite a Q2 revenue beat, as the company's full-year guidance raise adds just $244K to the second-half midpoint.
Chip Rally Shields Tech From Rate Jitters as Jobs Data Surprises
Strong August jobs data revived rate concerns, dragging the S&P 500 down 0.4%. Chip stocks surged 3.5% on resilient demand, while small caps gained.
UiPath Shares Plunge 17% as ARR Growth Target Slows
UiPath (PATH) shares dropped 17% after Q2 results, as the company's full-year ARR guidance implies a significantly faster growth pace in the second half.
UiPath Stock Rises 3% Ahead of Q2 Report as ARR Guidance Disappoints
UiPath shares gained 3% ahead of Q2 earnings, but the company's ARR guidance midpoint is 38% below Q1 net additions, signaling slower growth.
UiPath Stock Dips as Q2 Revenue Growth Forecast Slows to 10%
UiPath shares slipped 1.2% in premarket after guidance indicated revenue growth of just 9.2%-10.6% for the fiscal second quarter, with results due Thursday.
UiPath Stock Trades 29% Above Analyst Targets Ahead of Q2 Report
UiPath shares are trading 29% above the average analyst target ahead of Thursday's earnings report, with revenue guidance pointing to a sequential decline.
UiPath Stock Surges 63% Above Q1 Buyback Price Ahead of Earnings
UiPath (PATH) closed at $18.67, up 2.9%, trading 62.8% above its Q1 average buyback price of $11.47, as investors await fiscal Q2 earnings on Sept. 3.
UiPath Short Interest at 29% as Q2 ARR Guidance Nears $2B
UiPath shares fell nearly 1% to $18.15 as short interest hits 29% ahead of earnings. Investors eye ARR guidance near $1.93B.
UiPath Options Signal 11% Swing as Q2 Earnings Loom
UiPath shares slipped 1% as options traders anticipate an 11% swing after Q2 earnings. Q1 revenue grew 17%, but Q2 guidance points to deceleration, pressuring valuation.
UiPath Shares Edge Lower Ahead of Q2 Earnings; Valuation at 4.9x ARR
UiPath (PATH) slipped 1% to $18.15 as investors await Q2 results due Sept 3. With a $9.4B market cap and ARR guidance of $1.929B-$1.934B, the stock trades at 4.9x projected ARR.
UiPath Eases 1% After Rally, Valuation at 4.9x ARR Ahead of Q2 Report
UiPath shares eased 0.98% to $18.15 after a 9.37% rally, with valuation at 4.9x ARR. Q2 earnings due Sept 3.
UiPath Stock Trades 18% Above Analyst Targets as Maestro Flow Launch Nears Earnings
UiPath shares trade 18% above analyst targets following Maestro Flow launch. Earnings on September 3 will test whether product expansion can offset slowing revenue growth.
UiPath Shares Climb 1.3% as Valuation Outpacing Analyst Targets
UiPath shares rose 1.3% after unveiling Maestro Flow, now trading 19% above Wall Street's average target. Q2 results due Sept 3 will test sales execution.
UiPath Stock Trades 14% Above Analyst Targets Ahead of Q2 Earnings
UiPath shares are 14% above the consensus analyst target, with Q2 earnings due September 3. Investors await ARR acceleration and margin performance.
UiPath Holds Steady at $15.99 as Rally Outpaces Analyst Targets
UiPath (PATH) closed at $15.99, up 43% over 52 weeks, now trading 16% above analyst targets. Heavy volume and strong Q1 results highlight execution risks.
UiPath Stock Soars Past Analyst Targets After Q1 Beat
UiPath shares have surged 25.5% since July 31, trading above analyst targets. Q1 results beat expectations, but Q2 guidance signals a sequential revenue decline.
UiPath Shares Outpace Analyst Targets Amid Insider Sale
UiPath (PATH) ended the week up 6.4%, trading 18% above the average analyst target, even as the chief accounting officer sold $831,250 in stock.
UiPath Stock Surges 18% as Rally Outpaces Wall Street Targets
UiPath (NYSE:PATH) shares surged 18% in a week, closing above analyst targets despite slowing ARR growth. Q2 earnings due September 3.
UiPath Stock Soars 18% as Shares Outpace Unchanged Earnings Outlook
UiPath (NYSE:PATH) shares jumped 18% last week to $15.05, yet analyst earnings forecasts remain unchanged. Q2 results are due September 3.
UiPath Stock Surges 29% Ahead of Q2 Earnings, But Analysts Remain Cautious
UiPath shares rallied 29% since late July, closing at $14.00 on Thursday. Trading volume spiked, but analysts' average target sits 5% below the current price.
UiPath Shares Reach Analyst Target as Q2 ARR Growth Slows
UiPath shares closed at $13.82, aligning with the consensus target, yet Q2 net new ARR is projected at $30.5M, roughly unchanged year-over-year.
UiPath Stock Jumps 8% as Shares Break Past Wall Street's Average Price Target
UiPath shares surged 8% to $14.10, closing above the average analyst target. The move was driven by sector momentum, but Q2 guidance points to a slowdown in ARR growth.
UiPath Rallies 5.7% as AI Optimism Lifts Automation Stocks
UiPath (PATH) rose 5.7% as AI stocks rallied, but its guidance reveals a slower ARR growth pace, raising questions about its second-half targets.
UiPath Stock Rebounds 18% as Buybacks Soften ARR Growth Miss
UiPath (PATH) shares jumped 18% after share buybacks helped cushion a softer ARR outlook. Cash reserves support valuation despite growth concerns.
UiPath Stock Surges 14% Despite Tepid ARR Growth Forecast
UiPath (NYSE:PATH) shares are up 14% despite Q2 guidance pointing to a 38% drop in net-new ARR. The company faces a challenging demand environment amid intense AI competition.
UiPath Stock Slides on Weak ARR Growth Forecast for Q2
UiPath stock dropped 3.3% after the company projected Q2 net new ARR between $28M and $33M, a 38% decline from Q1, signaling decelerating growth.
UiPath Stock Rises 22% in Four Days as Cash Position Offsets ARR Concerns
UiPath shares rose 22.5% in four days, fueled by a $1.42 billion cash position and buybacks, but net new ARR growth is slowing.